Latest Breaking News On - Pharming adss - Page 1 : comparemela.com

Pharming Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq Listed ADSs Costs for conversion of Ordinary Shares into ADS s waived by JP Morgan Chase for initial four weeks after today LEIDEN, Netherlands, Dec. 22, 2020 /PRNewswire/ Pharming Group N.V. ( Pharming or the Company ) (Euronext Amsterdam: PHARM), a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs, today separately announced that in connection with the listing of American Depositary Shares ( ADSs ) representing ordinary shares of nominal value of €0.01 each in the capital of the Company ( Ordinary Shares ) on the Nasdaq Global Market ( Nasdaq ), the United States Securities and Exchange Commission has declared effective registration statements on Form F-1 and F-6 with respect to such securities, Nasdaq has approved the ADSs for listing, and ADSs will begin tra

United statesUnited kingdomCity ofNoord hollandSusanne embletonPharming adssEuroclear nederlandFoster mitchell mary whittowBnp paribasJpmorgan chase bankCompany ordinaryExchange commissionPharming groupnv adssPrnewswire pharming groupnvEuropean unionPharming group